Javascript must be enabled to continue!
ABSTRACT NUMBER: ESOC2026A961 ESUS BEYOND ATRIAL FIBRILLATION: THE IMPORTANCE OF ONCOLOGICAL INVESTIGATION
View through CrossRef
Abstract
Background and aims
Approximately 30% of ischaemic cerebrovascular events remain of undetermined aetiology, including Embolic Stroke of Undetermined Source (ESUS). Beyond atrial fibrillation (AF), other potential mechanisms have been identified, such as artery-to-artery embolism, patent foramen ovale (PFO), and hypercoagulable states, particularly those associated with malignancy. It is estimated that 5–10% of ESUS cases are related to neoplastic disease.
Methods
Retrospective study of patients admitted with TIA or ischaemic stroke since 2021, classified as undetermined at discharge from the Stroke Unit, and followed for at least two years.
Results
Ninety-nine patients were included (47.5% women; mean age 73.1 ± 11.8 years). Five patients had active malignancy at the time of the index event, and eight were diagnosed during follow-up, totalling 13 cases (13.1%). A causal relationship was assumed in three patients, two of whom were anticoagulated. Two additional patients were subsequently diagnosed with AF and anticoagulated. In the remaining cases, no causal relationship was assumed due to localised disease or absence of recognised prothrombotic potential. During follow-up, AF was detected in 11 of 58 patients who underwent rhythm monitoring; PFO was identified in four of 22 investigated patients, and artery-to-artery embolism was presumed in three cases. Stroke recurrence occurred in three patients, one associated with active malignancy.
Conclusions
Despite the absence of systematic oncological screening, more than 10% of patients initially classified as having ESUS had a diagnosis of cancer at baseline or during follow-up. These findings highlight the relevance of considering malignancy in selected ESUS patients, given its implications for secondary prevention.
Conflict of interest
Jorge M. Ferreira Machado: nothing to disclose, Teresa Medeiros: nothing to disclose, Sofia Tavares: nothing to disclose, Diogo Fitas: nothing to disclose, Sandra Moreira: nothing to disclose, Cristina Duque: nothing to disclose, Maria João Lima: nothing to disclose
Oxford University Press (OUP)
Title: ABSTRACT NUMBER: ESOC2026A961 ESUS BEYOND ATRIAL FIBRILLATION: THE IMPORTANCE OF ONCOLOGICAL INVESTIGATION
Description:
Abstract
Background and aims
Approximately 30% of ischaemic cerebrovascular events remain of undetermined aetiology, including Embolic Stroke of Undetermined Source (ESUS).
Beyond atrial fibrillation (AF), other potential mechanisms have been identified, such as artery-to-artery embolism, patent foramen ovale (PFO), and hypercoagulable states, particularly those associated with malignancy.
It is estimated that 5–10% of ESUS cases are related to neoplastic disease.
Methods
Retrospective study of patients admitted with TIA or ischaemic stroke since 2021, classified as undetermined at discharge from the Stroke Unit, and followed for at least two years.
Results
Ninety-nine patients were included (47.
5% women; mean age 73.
1 ± 11.
8 years).
Five patients had active malignancy at the time of the index event, and eight were diagnosed during follow-up, totalling 13 cases (13.
1%).
A causal relationship was assumed in three patients, two of whom were anticoagulated.
Two additional patients were subsequently diagnosed with AF and anticoagulated.
In the remaining cases, no causal relationship was assumed due to localised disease or absence of recognised prothrombotic potential.
During follow-up, AF was detected in 11 of 58 patients who underwent rhythm monitoring; PFO was identified in four of 22 investigated patients, and artery-to-artery embolism was presumed in three cases.
Stroke recurrence occurred in three patients, one associated with active malignancy.
Conclusions
Despite the absence of systematic oncological screening, more than 10% of patients initially classified as having ESUS had a diagnosis of cancer at baseline or during follow-up.
These findings highlight the relevance of considering malignancy in selected ESUS patients, given its implications for secondary prevention.
Conflict of interest
Jorge M.
Ferreira Machado: nothing to disclose, Teresa Medeiros: nothing to disclose, Sofia Tavares: nothing to disclose, Diogo Fitas: nothing to disclose, Sandra Moreira: nothing to disclose, Cristina Duque: nothing to disclose, Maria João Lima: nothing to disclose.
Related Results
Left atrial function index in embolic stroke of undetermined source: A case-control study
Left atrial function index in embolic stroke of undetermined source: A case-control study
Background & Objectives: Previous studies showed left atrial volume index (LAVi) is a precise surrogate of atrial cardiopathy and associated with new-onset atrial fibrillation ...
Abstract WP406: Endothelial Function is Impaired in Embolic Stroke of Undetermined Source (ESUS)
Abstract WP406: Endothelial Function is Impaired in Embolic Stroke of Undetermined Source (ESUS)
Background:
Impairment of endothelial function is associated with atherosclerosis and atrial fibrillation, and could underlie several types of ischemic stroke. Recently...
Sex-Specific Risk Factors of Nonstenotic Carotid Plaque in Embolic Stroke of Unknown Source: A Case-Control Study
Sex-Specific Risk Factors of Nonstenotic Carotid Plaque in Embolic Stroke of Unknown Source: A Case-Control Study
BACKGROUND:
Many ischemic strokes are diagnosed as embolic strokes of undetermined source (ESUS). Recent evidence suggests that nonstenotic carotid plaque (nsCP) may be...
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
It has been appreciated for a long time that atrial flutter and atrial fibrillation have a clinical relationship. Now, with the technological advances that permit more sophisticate...
Adiponectin and Lone atrial fibrillation
Adiponectin and Lone atrial fibrillation
Objective: Lone atrial fibrillation is an idiopathic arrhythmia seen in younger individuals without any secondary disease. Adiponectin is an endogenous adipocytokine that increases...
RELATIONSHIP BETWEEN ATRIAL FIBRILLATION CARDIOVERSION AND F
RELATIONSHIP BETWEEN ATRIAL FIBRILLATION CARDIOVERSION AND F
Objectives
To investigate the relationship between atrial fibrillation cardioversion and f wave in electrocardiogram, providing an ordinary and noninvasive method...
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
OBJECTIVE
To determine whether there is significant atrial or atrial appendage enlargement or functional remodelling as a result of one to two months of sustained...
Beyond Coronary Risk: Clinical Scores as Predictors of Atrial Fibrillation in Chronic Coronary Syndrome
Beyond Coronary Risk: Clinical Scores as Predictors of Atrial Fibrillation in Chronic Coronary Syndrome
Atrial fibrillation frequently coexists with chronic coronary syndrome, sharing common cardiovascular risk factors and pathophysiological mechanisms. Identifying patients with chro...

